Lumiera Health - Date of the Annual General and Special Meeting of Shareholders and Addition to the Board of Directors
Lumiera Health - Date of the Annual General and Special Meeting of Shareholders and Addition to the Board of Directors
The Company looks forward to updating shareholders on its corporate plans.Montreal, Quebec--(Newsfile Corp. - October 4, 2023) - Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera"), a company specializing in the development and commercialization of natural health products, is pleased to announce that it will hold its Annual General and Special Shareholder Meeting on November 14, 2023. The record date for the meeting is October 10, 2023.
魁北克蒙特利爾-(Newsfile Corp.-2023年10月4日)-Lumiera Health Inc.(TSXV：NHP)(“公司“或”盧米埃拉)，一家專門從事天然保健品開發和商業化的公司，高興地宣佈，它將於2023年11月14日召開年度股東大會和特別股東大會。會議的記錄日期為2023年10月10日。
Furthermore, the Company is pleased to announce that Mr. Shawn Moniz has agreed to join the Board of Directors, effective immediately. Mr. Moniz will bring to the Company tremendous expertise.
此外，公司高興地宣佈，肖恩·莫尼茲先生已同意加入董事會，立即生效。莫尼茲先生將為公司帶來巨大的專業知識。
Mr. Moniz has over 22 years of experience as a strategic marketing and brand strategist in the field of customer relationship management ("CRM") and consumer product goods ("CPG"), where he was involved in brand positioning and loyalty focus, marketing automation, digital data strategy and omni-channel data driven marketing. Mr. Moniz has served as Vice President, CRM Strategic Solutions in his most recent occupation before founding Happy Belly, where he currently serves as CEO. Mr. Moniz has delivered strategic growth solutions to numerous Fortune 500 companies in the health care vertical such as Pfizer, Astellas, Bayer, GSK and many others. Mr. Moniz's background and experience in the healthcare field will play a vital role in Lumiera's future.
Moniz先生在客戶關係管理(“CRM”)和消費品(“CPG”)領域擁有超過22年的戰略營銷和品牌策略師經驗，涉及品牌定位和忠誠度關注、營銷自動化、數位數據戰略和全渠道數據驅動營銷。莫尼茲先生在創立Happy Belly之前擔任客戶關係管理戰略解決方案副總裁總裁，目前擔任Happy Belly首席執行官。Moniz先生曾為許多醫療保健垂直領域的財富500強公司提供戰略增長解決方案，如輝瑞、安斯泰、拜耳、葛蘭素史克等。莫尼茲先生在醫療保健領域的背景和經驗將對Lumiera的未來起到至關重要的作用。
The Company looks forward to updating shareholders on its corporate plans.
該公司期待著向股東通報其公司計劃的最新情況。
The Board of Directors thanks Shareholders, Customers, and Suppliers for their patience over the past months. Further details will be provided when available.
董事會感謝股東、客戶和供應商在過去幾個月裡的耐心。如有更詳細的資料，我們將會提供。
About Lumiera Health
關於Lumiera Health
Lumiera specializes in the development and commercialization of consumer products for the natural health industry. The Company sells herbal tonics and natural supplements through its Holizen Laboratories division, with a diverse portfolio including a line of innovative sleep aids. The Company is also commercializing a unique topical product line acting on the endocannabinoid system, without the use of cannabis, that provides an innovative solution for chronic pain and inflammation. A pioneer in the natural health innovation space, the Lumiera brand is rooted in the core values of science, nature and compassion. Our goal is to make people's lives better by developing natural health and wellness products that are effective, safe and trustworthy.
Lumiera專門從事自然健康行業消費產品的開發和商業化。該公司通過其Holizen實驗室部門銷售草藥補充劑和天然補充劑，產品組合多樣化，包括一系列創新的睡眠輔助設備。該公司還在商業化一種獨特的局部產品線，該產品線作用於內源性大麻系統，不使用大麻，為慢性疼痛和炎症提供了一種創新的解決方案。作為自然健康創新領域的先驅，Lumiera品牌植根於科學、自然和同情心的核心價值觀。我們的目標是通過開發有效、安全和值得信賴的天然健康和健康產品，讓人們的生活更美好。
For more information visit: .
有關更多資訊，請訪問：。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Forward-looking information: Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions indicate such "forward-looking information" as they relate to Lumiera. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Lumiera's current views and intentions with respect to future events, and current information available to Lumiera, and are subject to certain risks, uncertainties and assumptions.
前瞻性資訊：本新聞稿中包含的某些陳述構成“前瞻性資訊”，這一術語在適用的加拿大證券法中有定義。“可能”、“應該”、“可能”、“將會”、“尋求”、“打算”、“計劃”、“預期”、“相信”、“估計”、“預期”以及類似的表達方式表示與Lumiera有關的此類“前瞻性資訊”。除歷史事實以外的所有陳述都可能是前瞻性資訊。此類陳述反映了Lumiera目前對未來事件的看法和意圖，以及Lumiera目前掌握的資訊，可能會受到某些風險、不確定性和假設的影響。
Such risks and uncertainties include, among others, the risk factors included in Lumiera's annual management's discussion and analysis for the year ended November 30, 2022, which is available under the issuer's SEDAR profile at sedarplus.ca. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Lumiera in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Lumiera does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Lumiera undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
這些風險和不確定因素包括Lumiera管理層在截至2022年11月30日的年度討論和分析中包括的風險因素，這些討論和分析可在發行人的SEDAR簡介中查閱，網址為sedarplus.ca。在提供前瞻性資訊時採用了重大因素或假設。如果這些風險或不確定性中的一個或多個成為現實，許多因素可能會導致這些前瞻性資訊可能表達或暗示的實際結果、業績或成就與本文描述的結果、業績或成就不同。如果任何因素以意想不到的方式影響Lumiera，或者前瞻性資訊背後的假設被證明是不正確的，實際結果或事件可能與預測的結果或事件大不相同。任何此類前瞻性資訊都明確地受到本警示聲明的限制。此外，Lumiera不對此類前瞻性資訊的準確性或完整性承擔責任。本新聞稿中包含的前瞻性資訊是截至本新聞稿發佈之日的資訊，Lumiera不承擔公開更新或修改任何前瞻性資訊的義務，除非適用法律要求。
For further information: Mr. André Rancourt, 514.500.0059, info@lumiera.ca
欲瞭解更多資訊，請聯繫：安德烈·蘭庫爾先生，電子郵件：́@Lumiera.ca
CO: Lumiera Health Inc.
公司：Lumiera Health Inc.
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。
